Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?

Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?

Abstract Background Glioblastoma (GBM) is the most common malignant brain tumor with median survival of 12-15 months. Owing to uncertainty in clinical outcome, additional prognostic marker(s) apart from existing markers are needed. Since overexpression of endothelin B receptor (ETBR) has been demons...

Full description

Bibliographic Details
Main Authors: Suhas Vasaikar, Giorgos Tsipras, Natalia Landázuri, Helena Costa, Vanessa Wilhelmi, Patrick Scicluna, Huanhuan L. Cui, Abdul-Aleem Mohammad, Belghis Davoudi, Mingmei Shang, Sharan Ananthaseshan, Klas Strååt, Giuseppe Stragliotto, Afsar Rahbar, Kum Thong Wong, Jesper Tegner, Koon-Chu Yaiw, Cecilia Söderberg-Naucler
Format: Article
Language:English
Published: BMC 2018-02-01
Series:BMC Cancer
Subjects:
Glioblastoma
Endothelin B receptor
Endothelin receptor antagonists
Online Access:http://link.springer.com/article/10.1186/s12885-018-4012-7

Internet

http://link.springer.com/article/10.1186/s12885-018-4012-7

Similar Items